<http://webisa.webdatacommons.org/prov/394922267>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/392802020> .
<http://webisa.webdatacommons.org/392802020>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/133415948>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/392802020> .
<http://webisa.webdatacommons.org/392802020>	<http://www.w3.org/ns/prov#value>	"Additional non-ophthalmic indications for the iRNA agents of the invention include cancer, including but not limited to renal and colon cancer, and psoriasis." .
<http://webisa.webdatacommons.org/392802020>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.es> .